Analytical Data
-
Gene name
ENPP-2
- Application
-
Alternative Names
ATX; ATX-X; LysoPLD; NPP2; PD-IALPHA; PDNP2; Autotaxin; Extracellular lysophospholipase D
-
Species
Rat
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
Q64610
-
Expression Region
Thr54~Trp254
-
Molecular Weight
26kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ENPP-2, also known as autotaxin, is a key enzyme involved in the hydrolysis of lysophosphatidylcholine (LPC) to produce lysophosphatidic acid (LPA), a bioactive lipid mediator that plays crucial roles in various physiological processes including cell proliferation, migration, and survival. Elevated levels of LPA are associated with several pathological conditions, such as cancer progression, inflammatory diseases, and neurological disorders. The study of ENPP-2 has garnered significant attention due to its potential as a therapeutic target for these illnesses. Recombinant ENPP-2 protein production allows researchers to investigate its structure, function, and regulation in greater detail, facilitating the development of ENPP-2 inhibitors or modulators. Understanding the enzymatic activity and molecular interactions of ENPP-2 can provide insights into its role in cellular signaling pathways and disease mechanisms, ultimately contributing to the identification of novel treatment strategies. Additionally, recombinant ENPP-2 can be utilized in various biochemical assays and drug screening processes, helping to fast-track the discovery of effective therapeutic agents aimed at modulating ENPP-2 activity. As research continues to unravel the complexities of ENPP-2's functions, it holds promise as a pivotal component in the pursuit of advanced therapies for a range of debilitating conditions.
